The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Laura-Maria Krabbe
No relevant relationships to disclose
Mary Elizabeth Westerman
No relevant relationships to disclose
Vitaly Margulis
No relevant relationships to disclose
Ganesh Raj
No relevant relationships to disclose
Arthur I. Sagalowsky
No relevant relationships to disclose
Kevin Dale Courtney
No relevant relationships to disclose
Yull Edwin Arriaga
No relevant relationships to disclose
Yair Lotan
No relevant relationships to disclose